THE EFFECT OF GUSELKUMAB ON ENTHESITIS: RESULTS FROM A PHASE 2 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

被引：1
|
作者：
Helliwell, P. [1 ]
Gottlieb, A. B. [2 ]
Deodhar, A. [3 ]
Boehncke, W. -H. [4 ]
McGonagle, D. [1 ]
Xu, X. L. [5 ]
Xu, S. [5 ]
Wang, Y. [5 ]
Hsia, E. C. [5 ,6 ]
Karyekar, C. S. [7 ]
Mease, P. [8 ,9 ]
机构：
[1] Univ Leeds, Leeds, W Yorkshire, England
[2] Metropolitan Hosp, NY Med Coll, New York, NY USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Univ Geneva, Geneva, Switzerland
[5] Janssen Res & Dev LLC, Spring House, PA USA
[6] Univ Penn, Philadelphia, PA USA
[7] Janssen Sci Affairs LLC, Horsham, PA USA
[8] Swedish Med Ctr, Seattle, WA USA
[9] Univ Wash, Seattle, WA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.5460
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0344
引用
收藏
页码：1037 / 1037
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
    Deodhar, Atul
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Dong, Bin
    Wang, Yuhua
    Zhuang, Yanli
    Barchuk, William
    Xu, Xie L.
    Hsia, Elizabeth C.
    LANCET, 2018, 391 (10136): : 2213 - 2224
  • [32] Efficacy and Safety Results of Guselkumab in Patients with Active Psoriatic Arthritis over 56 Weeks from a Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study
    Deodhar, Atul A.
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Dong, Bin
    Wang, Yuhua
    Zhuang, Yanli
    Barchuk, William
    Xu, Xie L.
    Hsia, Elizabeth
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [33] Effect of Secukinumab on Radiographic Progression Through 2 Years in Patients with Active Psoriatic Arthritis: End-of-study Results from a Phase III Study
    Mease, Philip
    Landewe, Robert B. M.
    Rahman, Proton
    Tahir, Hasan
    Singhal, Atul
    Boettcher, Elke
    Navarra, Sandra
    Readie, Aimee
    Mpofu, Shephard
    Delicha, Evie Maria
    Pricop, Luminita
    van der Heijde, Desiree
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [34] EFFICACY AND SAFETY RESULTS OF GUSELKUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OVER 56 WEEKS FROM A PHASE 2A, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Deodhar, A.
    Gottlieb, A. B.
    Boehricke, W-H.
    Dong, B.
    Wang, Y.
    Zhuang, Y.
    Barchuk, W.
    Xu, X. L.
    Hsia, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 201 - 201
  • [35] COMPARING COMPOSITE MEASURES OF DISEASE ACTIVITY IN PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED PHASE 2 TRIAL WITH GUSELKUMAB
    Helliwell, Philip
    Deodhar, Atul
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Xu, Xie L.
    Xu, Stephen
    Wang, Yuhua
    Hsia, Elizabeth C.
    Gladman, Dafna D.
    Ritchlin, Christopher T.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1843 - 1843
  • [36] Ultrasound Enthesitis Responsiveness versus Clinical Enthesitis Responsiveness: Week 52 Results of an Exploratory Analysis from a Phase 3b Study in Patients with Psoriatic Arthritis
    D'Agostino, Maria Antonietta
    Gaillez, Corine
    Schett, Georg
    Boers, Maarten
    Carron, Philippe
    Mandl, Peter
    Rosa, Javier
    Naredo, Esperanza
    Bakewell, Catherine
    Bao, Weibin
    Conaghan, Philip
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4436 - 4438
  • [37] Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
    Philip J. Mease
    Ana-Maria Orbai
    Oliver FitzGerald
    Mohamed Bedaiwi
    Rajiv Dona L. Fleishaker
    Pamela Mundayat
    Philip S. Young
    Arthritis Research & Therapy, 25
  • [38] EFFECTIVENESS OF ANTI-TNFS ON DACTYLITIS AND ENTHESITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM THE CORRONA PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS REGISTRY
    Mease, P. J.
    Singh, R.
    Douglas, K.
    Hua, D.
    Litman, H. J.
    Karki, C.
    Griffith, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1331 - 1331
  • [39] Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
    Mease, Philip J.
    Orbai, Ana-Maria
    FitzGerald, Oliver
    Bedaiwi, Mohamed
    Fleishaker, Dona L.
    Mundayat, Rajiv
    Young, Pamela S.
    Helliwell, Philip
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [40] Effect of Tofacitinib on Patient-Reported Outcomes in Patients with Active Psoriatic Arthritis: Results from 2 Phase 3 Studies
    Strand, Vibeke
    de Vlam, Kurt
    Covarrubias-Cobos, Jose A.
    Mease, Philip J.
    Gladman, Dafna D.
    Hendrikx, Thijs
    Kudlacz, Elizabeth
    Graham, Daniela
    Wu, Joseph
    Cappelleri, Joseph C.
    Hsu, Ming-Ann
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345